Volume 26, Number 9—September 2020
Dispatch
Clinicopathologic and Immunohistochemical Findings from Autopsy of Patient with COVID-19, Japan
Table 1
Characteristic | Day of illness |
||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cruise ship |
Hospital |
||||||||||||||||
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | ||
Symptom | |||||||||||||||||
Temperature, °C | 38.8 | 38.5 | 38.9 | 38.3 | 37.9 | 37.5 | 37.1 | 37.2 | 37.5 | 37.7 | 36.9 | ||||||
Dyspnea† | + | + | + | + | ++ | ++ | ++ | ++ | +++ | +++ | +++ | +++ | +++ | ||||
SaO2, % |
95–96 |
90–95 |
86–94 |
84–92 |
83–86 |
79–84 |
74–84 |
66–79 |
|||||||||
Intervention | |||||||||||||||||
O2 (L/min) | 2 | 5 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | ||||||||
ABPC/SBT | * | * | * | * | * | ||||||||||||
MPSL, HYD | * | * | * | * | * | * | |||||||||||
LPV/r | * | * | * | ||||||||||||||
Morphine |
* |
* |
* |
||||||||||||||
Blood test result | |||||||||||||||||
Leukocytes, 103/µL | 3.7 | 4.2 | 12.4 | ||||||||||||||
PLT, 104/µL | 13.4 | 14.0 | 22.8 | ||||||||||||||
AST, U/L | 53 | 58 | 46 | ||||||||||||||
ALT, U/L | 25 | 26 | 28 | ||||||||||||||
CRE, mg/dL | 0.71 | 0.64 | 0.63 | ||||||||||||||
CRP, mg/dL | 2.66 | 3.40 | 1.32 |
*ABPC/SBT, ampicillin/sulbactam; ALT, alanine aminotransferase; AST, aspartate aminotransferase; CRE, creatinine; CRP, C-reactive protein; HYD, hydrocortisone; LPV/r, lopinavir/ritonavir; MPSL, methylprednisolone; PLT, platelet; SaO2, oxygen saturation.
†Dyspnea severity indicated by +, mild; ++, moderate; +++, severe.
Page created: May 15, 2020
Page updated: August 19, 2020
Page reviewed: August 19, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.